Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27690196 | 0.82 | LMNA (0.31) | ALDH1A1LMNAPOLB | |
| SCHEMBL11042103 | 0.80 | POLB (0.34) | LMNAPOLB | |
| SCHEMBL29169988 | 0.79 | MGAM (0.35) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL51192 | 0.78 | LMNA (0.46) | GAAALDH1A1TDP1LMNAPOLB | |
| SCHEMBL19400765 | 0.76 | — | — | |
| SCHEMBL8563170 | 0.76 | ALDH1A1 (0.36) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL19102478 | 0.76 | ALDH1A1 (0.32) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL13914924 | 0.76 | LMNA (0.32) | LMNAPOLB | |
| SCHEMBL2978610 | 0.76 | — | — | |
| SCHEMBL27742533 | 0.76 | LMNA (0.32) | ALDH1A1TDP1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 804 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400793-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-12-05 | — | — | US | claimed |
| EP-4396271-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | Momentive Performance Materials Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| CN-117843599-A | Preparation method of prostaglandin intermediate containing 1-alkyl-1-alkenyl ethanol structure | 广州楷石医药有限公司 | 2024-04-09 | — | — | CN | claimed |
| WO-2023034354-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2023-03-09 | — | — | WO | claimed |
| CN-115611760-A | Chemical synthesis method suitable for large-scale production of (S) -2-amino-5-alkynyl caproic acid | 天津药明康德新药开发有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-108569969-A | A kind of synthetic method of 3-aminophenylacetylene | 西安格瑞德化工新材料有限公司 | 2018-09-25 | — | — | CN | claimed |
| CN-106188006-A | Containing 1,2,3 triazole heterocycle compounds and its preparation method and application | 天津国际生物医药联合研究院 | 2016-12-07 | — | — | CN | claimed |
| CN-103724211-A | Preparation method for m-aminophenylacetylene | CHONGQING WORLD HAORUI PHARM CHEM CO LTD | 2014-04-16 | — | — | CN | claimed |
| US-8471043-B2 | Platensimycin derivatives, their intermediates, and process for preparing the same, and new process for preparing platensimycin | SNU R&DB FOUNDATION (KR) | 2013-06-25 | — | — | US | claimed |
| US-20120264011-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-10-18 | — | — | US | claimed |
| US-20110028741-A1 | Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin | SNU R&DB FOUNDATION (KR) | 2011-02-03 | — | — | US | claimed |
| WO-2009125938-A2 | NOVEL PLATENSIMYCIN DERIVATIVES, THEIR INTERMEDIATES, AND PROCESS FOR PREPARARING THE SAME, AND NEW PROCESS FOR PREPARING PLATENSIMYCIN | SNU R&DB FOUNDATION (KR) | 2009-10-15 | — | — | WO | claimed |
| US-6552239-B1 | Reacting ketophosphonate with diazo-transfer reagent generating a ketodiazophosphonate which is reacted with cyclopropanecarboxaldehyde | MERCK & CO., INC. | 2003-04-22 | — | — | US | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| US-4338466-A | PRECURSORS FOR OLIGOMERS EXHIBITING PROTECTION FOR OXIDATIVE PHOSPHORYLATION OF DEGENERATED MITOCHONDRIA | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1982-07-06 | — | — | US | claimed |
| CN-122094688-A | Compositions and methods for treating pulmonary arterial hypertension | — | 2026-05-26 | — | — | CN | disclosed |
| US-12570617-B2 | Use of triazole compound as ghrelin receptor agonist | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2026-03-10 | — | — | US | disclosed |
| EP-0121117-A1 | Derivatives of dihydropyridine and production thereof | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1984-10-10 | — | — | EP | disclosed |
| US-4388237-A | NEUROLEPTIC, SEDATIVE, HYPNOTIC, ANALGESIC, ANTIDEPRESSANT | BASF AKTIENGESELLSCHAFT (DE) | 1983-06-14 | — | — | US | disclosed |
| US-4246103-A | INHIBIT PRECIPITATION OF HARD WATER IONS ESPECIALLY FOR INDUSTRIAL WATER AND SLUDGE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028741-A1 | Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin | RPN2, RPN1, DHPS | MGAM 410/4885GAA 1097/4885SI 390/4885 |
| US-12570617-B2 | Use of triazole compound as ghrelin receptor agonist | GIPR, GLP1R, GCGR | MGAM 3851/4885GAA 3251/4885SI 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.